Blanks R G
Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton, Surrey, UK.
Cytopathology. 2010 Dec;21(6):379-88. doi: 10.1111/j.1365-2303.2010.00771.x.
The positive predictive value (PPV) for the detection of cervical intraepithelial neoplasia (CIN) grade 2 or worse of referral to colposcopy from moderate dyskaryosis or worse (equivalent to high-grade squamous intraepithelial lesion or worse) is a standard performance measure in the National Health Service cervical screening programme. The current target is to examine 'outlier' laboratories with PPVs outside the 10th-90th percentile, which automatically identifies 20% of laboratories for further investigation. A more targeted method of identifying outliers may be more useful.
A similar measure to the PPV, the abnormal predictive value (APV), can be defined as the predictive value for CIN2 or worse for referrals from borderline (includes atypical squamous and glandular cells) and mild dyskaryosis (equivalent to low-grade squamous intraepithelial lesion) combined. A scatter plot of the APV versus the PPV can be produced (the APV-PPV diagram). Three kinds of 'outlier' can be defined on the diagram to help determine laboratories with unusual data. These are termed a true outlier value (TOV) or an extreme value (EV) for either PPV or APV, or a residual extreme value (REV) from the APV-PPV best line of fit.
Using annual return information for 2007/8 from 124 laboratories, two were defined as having EVs for PPV (both had a relatively low PPV of 62%). For APV, four laboratories were considered to have EVs of 34%, 34%, 34% and 4% and one was considered to be a TO with an APV of 45%. Five were identified as REV laboratories, although three of these were also identified as having extreme or outlier values, leaving two that had not been identified by the other methods. A total of eight (6%) laboratories were therefore identified as meriting further investigation using this methodology.
The method proposed could be a useful alternative to the current method of identifying outliers. Slide exchange studies between the identified laboratories, particularly those at opposing ends of the diagram, or other further investigations of such laboratories, may be instructive in understanding why such variation occurs, and could therefore potentially, lead to improvements in the national programme.
在英国国家医疗服务体系宫颈筛查项目中,从中度核异质或更严重情况(等同于高级别鳞状上皮内病变或更严重情况)转诊至阴道镜检查来检测2级或更高级别的宫颈上皮内瘤变(CIN)的阳性预测值(PPV)是一项标准性能指标。当前目标是检查PPV处于第10百分位数至第90百分位数范围之外的“异常”实验室,这会自动确定20%的实验室进行进一步调查。一种更具针对性的识别异常值的方法可能会更有用。
与PPV类似的一项指标,即异常预测值(APV),可定义为来自边界情况(包括非典型鳞状和腺细胞)和轻度核异质(等同于低级别鳞状上皮内病变)合并情况转诊的CIN2或更严重情况的预测值。可以生成APV与PPV的散点图(APV - PPV图)。在该图上可定义三种“异常值”,以帮助确定数据异常的实验室。这些分别被称为PPV或APV的真正异常值(TOV)或极值(EV),或者是APV - PPV最佳拟合线的残差极值(REV)。
利用124个实验室2007/8年度回报信息,有两个实验室被定义为PPV的极值(两者PPV相对较低,均为62%)。对于APV,四个实验室被认为极值分别为34%、34%、34%和4%,一个实验室被认为是具有45% APV的真正异常值(TO)。五个实验室被确定为残差极值(REV)实验室,尽管其中三个也被确定为具有极值或异常值,剩下两个是其他方法未识别出的。因此,总共八个(6%)实验室被确定值得使用此方法进行进一步调查。
所提出的方法可能是当前识别异常值方法的一个有用替代方案。在所确定的实验室之间进行玻片交换研究,特别是图两端的那些实验室,或者对这些实验室进行其他进一步调查,对于理解这种差异为何会出现可能具有指导意义,因此有可能改进国家项目。